HABP2 and ovarian cancer: In our cohort, including borderline tumors and primary and recurrent ovarian cancer samples, we observed two main HA-deposition patterns by ligand histochemistry using a biotinylated HABP, the first one being localized directly around ovarian cancer cells and the second one present in the connective tissue stroma distant from the cancer cells.